Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
Adenosine A2A receptor agonists as anti-inflammatory agentsGail W SullivanExpert Opinion on Investigational Drugs|July 19, 2005
Adenosine A2A agonists in development for the treatment of inflammationCourtney M Lappas, Gail W Sullivan, Joel LindenThe Journal of Infectious Diseases|May 4, 2004
A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsisGail W Sullivan, Guodong Fang, Joel Linden, et al.The Biochemical Journal|July 19, 2005
Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor inductionLauren J Murphree, Gail W Sullivan, Melissa A Marshall, et al.American Journal of Respiratory and Critical Care Medicine|February 27, 2007
Blocking p21-activated kinase reduces lipopolysaccharide-induced acute lung injury by preventing polymorphonuclear leukocyte infiltrationJörg Reutershan, Rebecca Stockton, Alexander Zarbock, et al.The Journal of Infectious Diseases|May 10, 2002
Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and functionGerly A C Brito, Gail W Sullivan, William P Ciesla, et al.Journal of Leukocyte Biology|October 4, 2003
Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophilsGail W Sullivan, David D Lee, William G Ross, et al.Circulation Research|September 29, 2007
A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytesAdam N Clark, Rebecca Youkey, Xiaoping Liu, et al.Bioorganic & Medicinal Chemistry|February 7, 2006
Norbornyllactone-substituted xanthines as adenosine A(1) receptor antagonistsWilliam F Kiesman, Jin Zhao, Patrick R Conlon, et al.Circulation|July 31, 2002
Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivoLaurent M Riou, Mirta Ruiz, Gail W Sullivan, et al.Pageof 2